CGS 35601, a triple inhibitor of angiotensin converting enzyme, neutral endopeptidase and endothelin converting enzyme.

Battistini, Bruno; Daull, Philippe; Jeng, Arco Y

Battistini, Bruno; Daull, Philippe; Jeng, Arco Y.

Affiliation

Battistini B; Laval Hospital Research Center, Quebec Heart and Lung Institute, Department of Medicine, Laval University, Ste-Foy, QC G1V 4G5, Canada. bruno.battistini@med.ulaval.ca

Cardiovasc Drug Rev ; 23(4): 317-30, 2005.

Article in En | MEDLINE | ID: mdl-16614731

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/pharmacology; Antihypertensive Agents/pharmacology; Aspartic Acid Endopeptidases/antagonists & inhibitors; Enzyme Inhibitors/pharmacology; Indoles/pharmacology; Metalloendopeptidases/antagonists & inhibitors; Neprilysin/antagonists & inhibitors; Protease Inhibitors/pharmacology; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Animals; Antihypertensive Agents/chemistry; Antihypertensive Agents/therapeutic use; Diabetes Mellitus/drug therapy; Endothelin-Converting Enzymes; Enzyme Inhibitors/therapeutic use; Heart Failure/drug therapy; Humans; Hypertension/drug therapy; Indoles/chemistry; Indoles/therapeutic use; Protease Inhibitors/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protease Inhibitors / Angiotensin-Converting Enzyme Inhibitors / Metalloendopeptidases / Neprilysin / Aspartic Acid Endopeptidases / Enzyme Inhibitors / Indoles / Antihypertensive Agents Limits: Animals / Humans Language: En Journal: Cardiovasc Drug Rev Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2005 Document type: Article Affiliation country: Canada Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links